Later day contact lens discomfort is a frequent complaint amongst contact lens wearers. Historically treatments have been approached from the direction of lens design changes, often frequently and almost as often with little or no success. This trial used the CLDEQ-8 to query the frequency and intensity of 5 symptoms associated with contact lens discomfort, subjective scores, and clinical measures to assess the response to the planned treatments.
The results indicated that improving Meibomian Gland function can produce statistically significant improvements in the frequency, severity, and overall sum of subjective symptoms associated with dryness among SCL wearers, and therefore may reduce contact lens discomfort, aid patient retention and reduce contact lens drop-out.
I would encourage you to look especially at the CLDEQ-8 results and subject comments. The trial was funded by a grant from The Body Doctor Limited. Further product information can be obtained from The Body Doctor Limited by email
